Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...

Now that Novo Nordisk A/S’ blockbuster semaglutide franchise has been selected as one drug for the next round of the CMS price negotiation, the Bagsværd, Denmark-based company is asking a U.S.

On the positive side, Novo Nordisk also made headlines with the successful results of its STEP UP trial for Semaglutide 7.2 mg, which demonstrated a significant 20.7% weight loss over 72 weeks ...

Novo Nordisk recently published favorable results from the FLOW renal outcomes trial, which found that Ozempic (semaglutide) 1.0 mg lowered the risk of kidney disease progression and kidney and ...

57.3% of patients treated with CagriSema were on the highest dose compared to 82.5% with cagrilintide 2.4 mg and 70.2% with semaglutide 2.4 mg.” On this news, the price of Novo Nordisk stock ...

drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

The approval comes after the Biden administration selected three of Novo Nordisk's drugs with the active ingredient semaglutide for the second cycle of Medicare drug price negotiations.